Advertisement

Cardiology General

AKI & Nitric Oxide Synthase 3 Genetic Variant After Pediatric Cardiac Surgery

Sep 26, 2022

About 30-50% of young individuals who undergo heart surgery also suffer from acute kidney damage (AKI). AKI following heart surgery has been linked to genetic variations that influence renal blood flo...

Ischemic Cardiomyopathy: QoL Outcome Patterns

Sep 26, 2022

Patients with ischemic cardiomyopathy had better mean quality of life (QoL) scores after regular coronary artery bypass surgery (CABG) compared to guideline-directed medical therapy (GDMT), according ...

Aortic Valve Stenosis: Hemodynamics with Ventricular & Valvular Remodeling

Sep 26, 2022

When examining aortic valve stenosis (AS), researchers have frequently concentrated their attention on the effects of the condition on blood flow.  On the basis of hemodynamics and symptoms, interven...

Cardiovascular Maternal Morbidity: Black-White Disparity

Sep 26, 2022

The goal of this study was to synthesize the data on the racial differences in the incidence of cardiovascular maternal morbidity and death. To determine if there were any differences in the risk of c...

Patients’ Expectations Optimization: Heart Surgery Outcomes

Sep 26, 2022

Disability and quality of life 6 months following coronary artery bypass graft surgery (CABG) were found to be significantly improved by a brief intervention focused on patients' expectations before s...

KCCQ Validation in Symptomatic oHCM

Sep 13, 2022

Improving patients' symptoms, function, and quality of life is the primary focus of treatment for obstructive hypertrophic cardiomyopathy (oHCM). Patients with oHCM may or may not benefit from using t...

Dapagliflozin Effects Based on HFC Medical Therapy Score

Sep 13, 2022

Patients with heart failure (HF) and a diminished ejection fraction have been the focus of research by the Heart Failure Collaboratory (HFC), which has resulted in the creation of a score that conside...

SGLT2 Inhibitors & Cardiac Results in Anthracycline Patients

Sep 13, 2022

Patients with chronic heart failure fare better when treated with sodium-glucose co-transporter-2 (SGLT2) inhibitors. There was no information on the benefit of SGLT2 inhibitors among patients treated...

Expenditure on Heart Failure (HF) in the United States

Sep 13, 2022

Estimating current spending for patients with heart failure (HF) informs the worth of preventative health initiatives, which is important given the rising cost of healthcare in the United States. This...

Supranormal LVEF, Stroke Volume, and Cardiovascular Risk

Sep 13, 2022

An elevated cardiovascular disease (CVD) risk has been linked to echocardiographic evidence of a supranormal ejection fraction in patient populations referred for clinical care. Supranormal left ventr...

Predictors of Major Adverse Cardiovascular Outcomes in CHD

Aug 31, 2022

Clinicians need to implement strategies that improve adherence to and greater use of intensive therapies in secondary cardiovascular disease prevention. Patients with established coronary heart...

Antihypertensive & Statin Adherence Suboptimal in Medicare Recipients

Aug 29, 2022

In Medicare beneficiaries, antihypertensive and statin medication adherence was found to be suboptimal, and disparities were present. Hypertension and hypercholesterolemia are leading chronic ...

Left-Sided VHD Detection: Deep Learning ECG Analysis

Aug 23, 2022

Valvular heart disease continues to go undiagnosed while being a significant cause of cardiovascular morbidity and death. Electrocardiography (ECG) deep learning analysis may help identify mitral regu...

Cardiorespiratory Fitness & Mortality Risk Across Age, Race, and Sex

Aug 23, 2022

All-cause mortality and cardiorespiratory fitness (CRF) are negatively correlated. The relationship between CRF and mortality risk for various racial groups, women, and old people has not yet been tho...

SR Ivabradine Hemisulfate in Systolic Heart Failure Patients

Aug 23, 2022

Ivabradine works well to lower heart rate and enhance therapeutic outcomes in chronic heart failure patients with low ejection fraction (HFrEF). However, only the short-acting ivabradine formulation, ...

Cardiovascular (CV) Disease Projections in the United States

Aug 23, 2022

Planning for public health interventions and understanding changes in cardiovascular (CV) risk factors and illness by age, sex, race, and ethnicity are crucial. For a study, researchers sought to esti...

PVD Spectrum: Clinical Features and Transplant-Free Survival

Aug 23, 2022

Deep phenotyping will be used by PVDOMICS (Pulmonary Vascular Disease Phenomics), a precision medicine program, to describe pulmonary vascular disease (PVD). PVDOMICS investigates the claim that combi...

Balloon- vs Self-Expanding Valve Systems: Failed Small Surgical Aortic Valve Bioprostheses

Aug 23, 2022

Retrospective studies have provided information on valve system comparisons in the field of valve-in-valve transcatheter aortic valve replacement (ViV-TAVR). For a study, researchers sought to compare...

Discordant Grading & Flow-Gradient Patterns in Moderate AS

Aug 23, 2022

Discordant grading in severe aortic stenosis (AS) has well-known prognostic repercussions. The incidence of various flow-gradient patterns and the consequences for prognosis in mild AS remained unclea...

PCSK9 and HMG-CoA Reductase Inhibition & Cognitive Function

Aug 23, 2022

Although proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition and statin-based lipid-lowering medication are effective methods for lowering the risk of cardiovascular disease, worries rega...